drug · small molecule
bupivacaine hydrochloride
Marketedupdated 3mo agoby OncoZenge AB🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugAlevatrix2 co-mentions · 2 sources
- drugbupivacaine ER2 co-mentions · 2 sources
- tagDrug Shortage2 co-mentions · 2 sources
- drugbupivacaine2 co-mentions · 2 sources
- drugadrenaline1 co-mentions · 1 sources
- drugLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE1 co-mentions · 1 sources
- drugEPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE1 co-mentions · 1 sources
- drugEPINEPHRINE1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for pain and 25 investigational indications.
targets
Sodium channel protein type 4 subunit alpha
all catalysts(0)
nothing on the calendar yet
Trials studying bupivacaine hydrochloride
- phase2A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery
- phase3Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain
- phase2Study Assessing Pain Relief After Replacement of the Knee
- phase2Study Assessing Pain Relief After Replacement of the Knee
- —Impact of Opioid Avoidance Protocol for ACL Reconstruction
- phase2Sustained Release Lidocaine for the Treatment of Postoperative Pain
- phase3Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty
- phase4Comparison of Clorotekal and Bupivacaine for Short Obstetric Surgery
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 20, 2029
~2.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Jan 9, 2033formulationUS 11746141
- May 20, 2029method-of-use (U-2949)US RE478262.8y
News(2)
- Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose InjectionMedline is correcting affected convenience kits by removing recalled Lidocaine Hydrochloride and Bupivacaine Hydrochloride in Dextrose Injection components from affected convenience kits.fda_medwatch · 8d ago
- Convenience Kit Recall: B. Braun Medical, Inc. Removes Spinal Anesthesia Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USPB. Braun is removing affected convenience kits containing recalled Bupivacaine Hydrochloride in Dextrose Injection componentsfda_medwatch · 26d ago
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that